Page 31 - Bioscience Inc News Today

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced infertility treatment...

Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., April 11, 2023 /PRNewswire/ -- INVO Bioscience, Inc. , a commercial-stage fertility... | June 20, 2023

The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the historica...

Telesis Bio's technology allows for rapid at-the-benchtop synthesis, very long, high-fidelity genes without using toxic chemicals. We just use enzymes, so like water, salts and proteins to make the DNA oligos.

Operator: Welcome to the conference call hosted by Daré Bioscience to review the companys Financial Results for the Year Ended December 31, 2022 and to provide a general business update.

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – HC Wainwright issued their FY2027 earnings per share estimates for Daré Bioscience in a research note issued on Friday, March 31st. HC Wainwright analyst D. Tsao expects that the biotechnology company will post earnings of $0.80 per share for the year. HC Wainwright currently has a “Buy” […]

SCOTTSDALE, AZ / ACCESSWIRE / April 4, 2023 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has struck a vendor partnership

FinancialContent fully hosted finance channel

CBD Life Sciences, Inc. (CBDL) Executes Partnership with Arizonas ...

RESIGNATION OF DIRECTOR March 31, 2023 Boards of Directors INVO Bioscience, Inc. To whom it may concern: I tender... | April 4, 2023